See more : Premier Miton Group plc (PASMF) Income Statement Analysis – Financial Results
Complete financial analysis of Affymax, Inc. (AFFY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Affymax, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- SAS AB (publ) (SAS-DKK.CO) Income Statement Analysis – Financial Results
- New Sources Energy N.V. (NSE.AS) Income Statement Analysis – Financial Results
- China Jinmao Holdings Group Limited (0817.HK) Income Statement Analysis – Financial Results
- Look Holdings Incorporated (8029.T) Income Statement Analysis – Financial Results
- Armm Inc. (ARMM) Income Statement Analysis – Financial Results
Affymax, Inc. (AFFY)
About Affymax, Inc.
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
| Metric | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37M | 94.37M | 47.72M | 112.52M | 114.90M | 82.85M | 44.34M | 11.73M | 74.00K | 151.00K | 225.00K | 103.00K | 0.00 |
| Cost of Revenue | 11.86K | 44.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.36M | 49.41M | 47.72M | 112.52M | 114.90M | 82.85M | 44.34M | 11.73M | 74.00K | 151.00K | 225.00K | 103.00K | 0.00 |
| Gross Profit Ratio | 99.13% | 52.36% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 11.86M | 51.74M | 76.31M | 93.64M | 157.13M | 137.49M | 69.40M | 54.35M | 24.05M | 17.34M | 0.00 | 16.83M | 0.00 |
| General & Administrative | 27.53M | 89.71M | 0.00 | 33.33M | 36.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 27.53M | 89.71M | 32.82M | 33.33M | 36.72M | 34.09M | 24.08M | 11.09M | 10.03M | 4.93M | 0.00 | 5.53M | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.75M |
| Operating Expenses | 39.39M | 141.45M | 109.13M | 126.97M | 193.84M | 171.58M | 93.47M | 65.44M | 34.08M | 22.27M | 0.00 | 28.45M | -10.75M |
| Cost & Expenses | 39.39M | 186.41M | 109.13M | 126.97M | 193.84M | 171.58M | 93.47M | 65.44M | 34.08M | 22.27M | 0.00 | 28.45M | -10.75M |
| Interest Income | 21.00K | 77.00K | 169.00K | 275.00K | 934.00K | 4.55M | 11.39M | 5.55M | 1.41M | 439.00K | 0.00 | 645.00K | 521.00K |
| Interest Expense | 1.57M | 1.44M | 144.00K | 140.00K | 105.00K | 609.00K | 14.00K | 84.00K | 29.00K | 0.00 | 0.00 | 26.00K | 24.00K |
| Depreciation & Amortization | 722.00K | 1.99M | 2.18M | 2.21M | 2.12M | 1.60M | 614.00K | 704.00K | 729.00K | 860.00K | 0.00 | 6.09M | 2.28M |
| EBITDA | -14.29M | -89.94M | -59.04M | -11.72M | -75.72M | -84.33M | -48.52M | -53.01M | -33.28M | -21.26M | 225.00K | -22.26M | 2.28M |
| EBITDA Ratio | -2,722.72% | -97.45% | -123.75% | -12.60% | -66.05% | -103.44% | -109.55% | -451.67% | -45,039.19% | -14,264.24% | 100.00% | -21,300.97% | 0.00% |
| Operating Income | -15.05M | -92.04M | -61.41M | -14.45M | -78.94M | -88.73M | -49.14M | -53.71M | -34.01M | -22.12M | 225.00K | -28.35M | -10.75M |
| Operating Income Ratio | -1,099.05% | -97.53% | -128.68% | -12.84% | -68.71% | -107.10% | -110.83% | -458.04% | -45,958.11% | -14,647.68% | 100.00% | -27,519.42% | 0.00% |
| Total Other Income/Expenses | -1.54M | -1.40M | 40.00K | 374.00K | 1.00M | 2.50M | 11.43M | 5.42M | 1.43M | 720.00K | -225.00K | -320.00K | 4.00K |
| Income Before Tax | -16.58M | -93.44M | -61.37M | -14.07M | -77.94M | -86.23M | -37.71M | -53.75M | -33.96M | -21.84M | 0.00 | -28.67M | -10.74M |
| Income Before Tax Ratio | -1,211.25% | -99.01% | -128.60% | -12.51% | -67.84% | -104.08% | -85.06% | -458.41% | -45,891.89% | -14,461.59% | 0.00% | -27,830.10% | 0.00% |
| Income Tax Expense | -2.16M | -26.00K | 1.00K | 1.00K | -1.41M | 282.00K | 5.36M | -5.42M | -1.43M | -720.00K | 28.36M | -299.00K | 10.24M |
| Net Income | -14.42M | -93.41M | -61.37M | -14.08M | -76.53M | -86.51M | -43.07M | -48.29M | -32.58M | -21.40M | -28.36M | -28.05M | -10.24M |
| Net Income Ratio | -1,053.62% | -98.98% | -128.60% | -12.51% | -66.61% | -104.42% | -97.14% | -411.80% | -44,021.62% | -14,170.86% | -12,604.89% | -27,229.13% | 0.00% |
| EPS | -0.39 | -2.57 | -1.84 | -0.57 | -4.06 | -5.68 | -2.88 | -32.02 | -99.93 | -70.16 | -103.13 | -105.04 | -43.22 |
| EPS Diluted | -0.39 | -2.57 | -1.84 | -0.57 | -4.06 | -5.68 | -2.88 | -32.02 | -99.93 | -70.16 | -103.13 | -105.04 | -43.22 |
| Weighted Avg Shares Out | 37.45M | 36.34M | 33.29M | 24.49M | 18.87M | 15.22M | 14.94M | 1.51M | 326.00K | 305.00K | 275.00K | 267.00K | 237.00K |
| Weighted Avg Shares Out (Dil) | 37.45M | 36.34M | 33.29M | 24.49M | 18.87M | 15.22M | 14.94M | 1.51M | 326.00K | 305.00K | 275.00K | 267.00K | 237.00K |
No news found for: AFFY
Source: https://incomestatements.info
Category: Stock Reports